Provision of Cellulitis Optimal Antibiotic Treatment and Placebo Manufacturing

Concepts

• southampton
• pharmaceutical products
• nihr
• provision of cellulitis optimal antibiotic treatment
• placebo of the selected medication
• cellulitis optimal antibiotic treatment
• lower leg cellulitis
• manufacturer
• placebo manufacturing
• investigational medicinal product

Location

Description

Cellulitis Optimal Antibiotic Treatment (COAT) is a publicly-funded (NIHR) and academic-sponsored (University of Southampton) Clinical Trial of an Investigational Medicinal Product (CTIMP). Aim: To assess the effectiveness and safety of 5 days vs 7 days of flucloxacillin for lower leg cellulitis, and to evaluate the cost-consequences of a shorter course from an NHS and personal perspective. The purpose of this tender Is to locate a manufacturer able to produce and supply a placebo of the selected medication along with the actual medication packaged and delivered as required by the service and stated in the specification.

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.
• Contract is suitable for VCOs.

Other Information

All documents can be found using the project name or reference on the Universities tendering platform In-Tend (https://in-tendhost.co.uk/universityofsouthampton) All documents can be found using the project name or reference on the Universities tendering platform In-Tend (https://in-tendhost.co.uk/universityofsouthampton) https://in-tendhost.co.uk/universityofsouthampton